SPC
APLS icon

Slate Path Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Slate Path Capital’s Portfolio APLS Stock Details APLS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,068,000
Closed -$78.7M – 60
2023
Q3 		$78.7M Buy
+2,068,000
New +$78.7M 2.19% 20